Homburger advised UBS, PostFinance and Sygnum in connection with a joint CHF stablecoin sandbox
On April 8, 2026, UBS, PostFinance, Sygnum, Raiffeisen, Zürcher Kantonalbank, BCV and Swiss Stablecoin AG announced the launch of a joint CHF stablecoin sandbox. The new initiative will test potential use cases for a CHF stablecoin in Switzerland. In doing so, the partners are exploring ways to connect blockchain applications with the Swiss franc, aiming …
Homburger advised Bank of America, J.P. Morgan and UBS Switzerland AG et al. on SHL Medical AG’s refinancing
Homburger acted as counsel to Bank of America, J.P. Morgan and UBS Switzerland AG as bookrunners, mandated lead arrangers and coordinators and to UBS Switzerland AG as agent and security agent in connection with the refinancing of SHL Medical AG. Headquartered in Switzerland, SHL is a world-leading provider of drug delivery solutions such as autoinjectors …
Homburger advises Windward Bio on its USD 165 m Series B Financing
On May 4, 2026, Windward Bio Group AG, a private, clinical-stage biotechnology company committed to improving outcomes for people living with serious immunological diseases, announced an upsized USD 165 m crossover financing led by OrbiMed, with participation from existing Series A investors including Novo Holdings, Blue Owl Healthcare Opportunities, SR One, Omega Funds, RTW Investments, …
Continue reading “Homburger advises Windward Bio on its USD 165 m Series B Financing”
Homburger advised Landis+Gyr on the divestment of its EMEA business to AURELIUS
On April 8, 2026, Landis+Gyr Group AG, a global energy technology leader driving intelligent innovation across the grid, announced the successful completion of the divestiture of its Europe, Middle East and Africa (EMEA) business to AURELIUS, a global private equity investor.
Homburger advised Novartis Finance S.A. on its issuance of EUR 1.7 bn aggregate amount Fixed Rate Notes guaranteed by Novartis AG
On May 13, 2026, Novartis Finance S.A. successfully completed its issuance of EUR 600 m 3.100 per cent.
Homburger advised Zürcher Kantonalbank on the issuance of EUR 500 m 3.080 per cent. Fixed Rate Bonds
On May 18, 2026, Zürcher Kantonalbank successfully completed its issuance of EUR 500 m 3.080 per cent. Fixed Rate Bonds due May 18, 2029 (the Bonds).
Homburger advised UBS Switzerland AG with regard to BACHEM HOLDING AG’s CHF 500 m revolving credit facility
Homburger acted as counsel to UBS Switzerland AG in its capacity as Coordinating Bookrunning Mandated Lead Arranger, Original Lender and Agent in connection with BACHEM HOLDING AG’s new CHF 500 m revolving credit facility agreement.
Homburger advises Marriott International on its proposed joint venture with the Leali family, founders of the Lefay brand
On March 31, 2026, Marriott International (Nasdaq: MAR) and the Leali family, founders of Lefay, announced their plans to enter into a joint venture to bring the highly awarded luxury wellness hospitality brand Lefay into the Marriott portfolio. Completion of the transaction is subject to customary approvals and closing conditions.
Homburger advised UBS AG, acting through its Stamford branch, on its 3(a)(2) offering of USD 3.05 bn Senior Notes
On March 16, 2026, UBS AG, acting through its Stamford branch, successfully completed its issuance of (i) USD 500 m in aggregate principal amount of Floating Rate Senior Notes due 2029, (ii) USD 1.3 bn in aggregate principal amount of 4.302 per cent.
Homburger advised, inter alia, UBS AG on the establishment of and first issuance under the Liechtensteiner Pfandbriefe Programme of Liechtensteinisches Pfandbriefinstitut AG
On March 25, 2026, Liechtensteinisches Pfandbriefinstitut AG established a program for the issuance of Liechtensteiner Pfandbriefe issued by Liechtensteinisches Pfandbriefinstitut AG, with UBS AG, LGT Bank AG and Liechtensteinische Landesbank AG acting as dealers under the program. The Liechtensteiner Pfandbriefe issued under the program will be indirectly backed by a portfolio of mortgages in accordance …